Company
Beam Therapeutics
Breaking new ground to advance science with the potential to change lives
- Business model
- B2B
- Headquarters
- Cambridge, MA, United States
- Legal name
- Beam Therapeutics
- beamtx.com (opens in a new tab)
- LinkedIn (opens in a new tab)
- X (opens in a new tab)
- Careers (opens in a new tab)
Claim, correct or request removal
Record updated 8 October 2026
About
Pioneering CRISPR base editing for precision genetic medicines to treat disease.
Funding snapshot
- Total raised
- $399MSum of rounds, as of 2026-10-08Source (opens in a new tab)
- Latest round
- Undisclosed, $180M2020-02
Funding rounds
- IPO
- $180M2020-02, Announced
- Round, 2018
- $135M2018-11-08, SEC form D sold, 27 investors
- Round, 2018
- $83.6M2018-02-09, SEC form D sold, 21 investors
Loading relationship preview